Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel ROCK-II inhibitors prepared at Boehringer Ingelheim

May 24, 2012

ProINS-Tf fusion protein displays hypoglycemic activity

May 24, 2012

Repros submits revised documentation to FDA for Androxal studies

May 23, 2012

FDA approves expanded use of Levemir

May 23, 2012

Novel ER-alpha agonists patented

May 23, 2012

Unigene reports encouraging preclinical data on UGP-281

May 23, 2012

Novel AMPK activators designed by Roche

May 21, 2012

Levotofisopam proof-of-concept trial successfully completed

May 18, 2012

Trimel Pharmaceuticals begins enrollment in phase II Tefina trial

May 18, 2012

New treatments for obesity described by Takeda Pharmaceutical

May 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...